Dr. Mauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Center for Advanced Care
900 West Nelson St
Chicago, IL 60657Phone+1 773-296-7089Fax+1 773-296-7311
Summary
- Dr. Ann Mauer is an oncologist in Chicago, IL and is affiliated with Advocate Illinois Masonic Medical Center. She received her medical degree from Loyola University Chicago Stritch School of Medicine and has been in practice 25 years. She specializes in breast cancer, cancer genetics/cancer risk assessment, and hematologic oncology and is experienced in breast cancer, lung cancer, and general medical oncology. She has more than 100 publications and over 500 citings.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 1995 - 1998- University of ChicagoResidency, Internal Medicine, 1992 - 1995
Loyola University Chicago Stritch School of MedicineClass of 1992
Certifications & Licensure
IL State Medical License 1995 - 2026- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer Start of enrollment: 1999 Nov 01
- Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach Start of enrollment: 2000 Feb 01
- Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer Start of enrollment: 2000 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 43 citationsRandomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.Hyman B. Muss, Mei Yin C. Polley, Donald A. Berry, Heshan Liu, C. Cirrincione
Journal of Clinical Oncology. 2019-07-24 - 5 citationsClinical Germline Diagnostic Exome Sequencing for Hereditary Cancer: Findings Within Novel Candidate Genes Are PrevalentZöe Powis, Carin R. Espenschied, Holly LaDuca, Kelly D. Farwell Hagman, Tripti Paudyal
Cancer Genetics. 2018-08-01 - 11 citationsLong-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.Nicholas W. Choong, Ann M. Mauer, Daniel Haraf, Mark K. Ferguson, Alan Sandler
Medical Oncology. 2011-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
